HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527,579 | -21.8% | 31,144 | -44.6% | 0.00% | – |
| Q2 2023 | $674,376 | -44.7% | 56,198 | -40.0% | 0.00% | – |
| Q1 2023 | $1,218,581 | +263.6% | 93,593 | +312.8% | 0.00% | – |
| Q4 2022 | $335,107 | -70.4% | 22,673 | -82.3% | 0.00% | – |
| Q3 2022 | $1,133,000 | -32.8% | 127,911 | -4.1% | 0.00% | – |
| Q2 2022 | $1,686,000 | -87.4% | 133,426 | -81.2% | 0.00% | -100.0% |
| Q1 2022 | $13,395,000 | -43.9% | 707,978 | +4.1% | 0.00% | -50.0% |
| Q4 2021 | $23,861,000 | -8.5% | 680,169 | -4.5% | 0.00% | -33.3% |
| Q3 2021 | $26,081,000 | +13.6% | 712,394 | +21.8% | 0.00% | +50.0% |
| Q2 2021 | $22,968,000 | +47.8% | 584,885 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $15,545,000 | +7.8% | 550,287 | +22.2% | 0.00% | 0.0% |
| Q4 2020 | $14,416,000 | -6.1% | 450,205 | -5.2% | 0.00% | 0.0% |
| Q3 2020 | $15,346,000 | +33.8% | 475,091 | +14.2% | 0.00% | 0.0% |
| Q2 2020 | $11,469,000 | +98.7% | 415,860 | +28.5% | 0.00% | +100.0% |
| Q1 2020 | $5,773,000 | -26.5% | 323,521 | +3.3% | 0.00% | 0.0% |
| Q4 2019 | $7,850,000 | +44.8% | 313,072 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $5,420,000 | -8.5% | 303,828 | +12.9% | 0.00% | 0.0% |
| Q2 2019 | $5,922,000 | -26.5% | 269,203 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $8,053,000 | +80.0% | 263,341 | +35.9% | 0.00% | 0.0% |
| Q4 2018 | $4,474,000 | +3315.3% | 193,759 | +4660.7% | 0.00% | – |
| Q3 2018 | $131,000 | +42.4% | 4,070 | +32.7% | 0.00% | – |
| Q2 2018 | $92,000 | -13.2% | 3,067 | -14.7% | 0.00% | – |
| Q1 2018 | $106,000 | +135.6% | 3,594 | +210.4% | 0.00% | – |
| Q4 2017 | $45,000 | +1025.0% | 1,158 | +606.1% | 0.00% | – |
| Q3 2017 | $4,000 | -76.5% | 164 | -77.7% | 0.00% | – |
| Q2 2017 | $17,000 | -19.0% | 737 | -28.4% | 0.00% | – |
| Q1 2017 | $21,000 | +425.0% | 1,030 | +243.3% | 0.00% | – |
| Q4 2016 | $4,000 | +100.0% | 300 | +64.8% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 182 | -1.6% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 185 | +8.8% | 0.00% | – |
| Q1 2016 | $2,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |